Previous 10 | Next 10 |
Smith+Nephew to feature Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2022 Annual Meeting PR Newswire LONDON , March 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology bu...
RBC Capital Markets has initiated Smith & Nephew (SNN +3.3%) with an outperform rating, citing the medical device company's potential acceleration in revenue growth and margins. The firm has a GBP1700 price target (41% upside based on Tuesday's close). Analyst Jack Reynolds-Clark said tha...
Smith+Nephew embarks on the OXINIUM™ Technology Tour of Change; a mobile learning exhibit to showcase the best performing bearing for total hip arthroplasty PR Newswire LONDON , March 15, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global m...
Defensive stocks are known for exhibiting stability during wild price swings in the market. And growing sanctions on Russia and the unstable nature of crude oil prices may drive further volatility in the market. So, we think it could be wise to bet now on defensive stocks CVS Health (CVS), Be...
Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple of months. But given the near-inelastic demand for healthcare solutions and the industry...
Smith & Nephew plc (SNN) Q4 2021 Earnings Conference Call February 22, 2022 03:30 AM ET Company Participants Roland Diggelmann - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Tom Jones - Berenberg Veronika ...
The following slide deck was published by Smith & Nephew plc in conjunction with their 2021 Q4 earnings call. For further details see: Smith & Nephew plc 2021 Q4 - Results - Earnings Call Presentation
Smith & Nephew (NYSE:SNN) appointed Deepak Nath as CEO, effective April 1, succeeding Roland Diggelmann, who will step down by mutual agreement on March 31. Nath joins Smith+Nephew from Siemens Healthineers (OTCPK:SEMHF) (OTCPK:SMMNY) where most recently he was p...
Smith & Nephew (NYSE:SNN) board recommended a final dividend of 23.1¢ per share (46.2¢ per ADS). The company said that together with the Interim Dividend of 14.4¢ per share (28.8¢ per ADS), this will give a total distribution of 37.5¢ per share (75.0¢ per ADS...
Smith & Nephew press release (NYSE:SNN): FY Adjusted EPS $0.809 (+25% Y/Y); ($1.618 per ADS) Revenue of $5.21B (+14.3% Y/Y) misses by $10M. Operating profit $593M (+101% Y/Y). Trading profit $936M (+37% Y/Y) Outlook: For 2022 the company is targeting underlying revenu...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...